US 8741306
Kidney specific tumor vaccine directed against kidney tumor antigen G-250
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 8741306 (Kidney specific tumor vaccine directed against kidney tumor antigen G-250) held by The Regents of the University of California expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/55516, A61K2039/55522